Hikma Pharmaceutical | HIK - Passifs Courants





Passifs Courants Changement Date
Almirall EUR 323.65M 26.99M 2026-06
argenx SE USD 1.58B 254.81M 2026-06
AstraZeneca USD 31.27B 286M 2026-09
Autolus Therapeutics Ltd USD 98.65M 29.86M 2026-09
Bayer EUR 29.4B 2.87B 2026-09
Fresenius EUR 8.08B 986M 2026-09
Genmab DKK 1.14B 38M 2026-06
GlaxoSmithKline GBP 20.72B 814M 2026-09
GRIFOLS EUR 2.3B 59M 2026-09
Hikma Pharmaceutical USD 1.45B 603M 2025-12
Lakefront Biotherapeutics EUR 70.32M 30.1M 2026-06
Lonza CHF 3.57B 421M 2025-12
Merck EUR 8.12B 1.22B 2026-06
Orion EUR 491.8M 37.3M 2026-09
Recordati EUR 1.4B 4.3M 2026-09
Roche Holding CHF 28.85B 846M 2026-06
Sanofi EUR 29.77B 2.16B 2026-09
UCB EUR 4.4B 470M 2025-12